BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
See today's BioWorld Science
Home
» DZD-1516 shows improved brain penetrance and efficacy in CNS metastases
To read the full story,
subscribe
or
sign in
.
Cancer
DZD-1516 shows improved brain penetrance and efficacy in CNS metastases
July 14, 2023
Half of patients with HER2-positive advanced breast cancer develop metastases in the central nervous system (CNS), even while receiving HER2-directed therapies.
BioWorld Science
Cancer
